GlassScriptPhysician profile
Stacey L Hall
NPI 1760950547
$9,614.34
in general payments reported to CMS, 2019-2025
43 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,807 · 2022: $2,047 · 2023: $2,847 · 2024: $1,777 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,250 · Travel and Lodging: $463 · Education: $47.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,249.86 |
| Travel and Lodging | $462.96 |
| Education | $47.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,221.72 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $800.98 | 2021-2024 | Myrbetriq |
| Janssen Biotech, INC. | $718.35 | 2021-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $614.96 | 2023-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $576.43 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $468.25 | 2021-2025 | |
| Laborie Medical Technologies Corp. | $379.71 | 2023-2025 | Urgent PC Neuromodulation System, Endosheath Technology |
| Pfizer INC. | $376.56 | 2021-2024 | |
| Medtronic, INC. | $338.46 | 2021-2025 | Interstim |
| Myriad Genetic Laboratories, INC. | $328.56 | 2021-2024 | Prolaris |
| Valencia Technologies Corporation | $307.35 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $285.43 | 2021-2024 | Speedicath |
| Boston Scientific Corporation | $252.34 | 2021-2025 | Spaceoar Vue System - 10ml, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Rezum Generator |
| Srs Medical Systems, INC. | $247.82 | 2021-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Rochester Medical Corporation | $243.97 | 2021-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $230.51 | 2021-2023 | Xiaflex |
| Halozyme INC | $200.44 | 2023 | |
| Myovant Sciences INC. | $193.53 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $184.65 | 2021-2022 | |
| Urogen Pharma, INC. | $176.13 | 2022-2025 | Jelmyto |
| Tolmar, INC. | $170.93 | 2023 | |
| Urovant Sciences INC | $132.91 | 2021-2022 | |
| Allergan, INC. | $125.78 | 2022 | |
| Clarus Therapeutics INC. | $118.56 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $103.98 | 2021-2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $103.20 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $96.63 | 2023-2024 | Tlando, Trelstar |
| 180 Medical, INC. | $95.71 | 2021-2023 | Gentlecath |
| Antares Pharma, INC. | $82.58 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $53.65 | 2022 | |
| Hologic Sales and Service, LLC | $50.44 | 2023 | Aptima |
| Mycovia Pharmaceuticals, INC. | $45.60 | 2023 | Vivjoa |
| Amgen INC. | $45.18 | 2021-2022 | |
| Olympus America INC. | $36.04 | 2022-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Millicent US INC | $34.62 | 2023 | Intrarosa, Femring |
| Procept Biorobotics Corporation | $28.24 | 2024 | Aquabeam System |
| Pacira Pharmaceuticals Incorporated | $25.42 | 2025 | Exparel |
| Lsi Solutions INC | $23.41 | 2024 | Ti-Knot, Jnw Urtrac, Running Device |
| Abc Home Medical Supply, INC. | $22.97 | 2024 | |
| Progenics Pharmaceuticals, INC. | $14.20 | 2023 | Pylarify |
| Kowa Pharmaceuticals America, INC. | $11.74 | 2022 | |
| Davol INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.